Zepbound Half-Life: How Long It Stays in Your System

Zepbound at a glance:

• Drug class: Dual GIP / GLP-1 receptor agonist
• Manufacturer: Eli Lilly
• FDA approved: 2023
• Route: subcutaneous injection (single-dose pen)
• Typical frequency: once weekly
• Half-life: approximately 5 days
• Cash price (US): $1,000-$1,100/month without insurance
• Receptor target: GIP and GLP-1 receptors (dual)

Zepbound stays active in your system for a defined period after each dose. The half-life is approximately 5 days, and that single fact drives the dosing schedule, the missed-dose rules, and the washout timeline.

Half-Life Defined

The half-life is the time it takes for the concentration of a drug in the bloodstream to fall by half. It governs how often a drug needs to be dosed to maintain therapeutic levels and how long the drug persists after the last dose.

For Zepbound, the half-life is approximately 5 days. That number explains the once weekly dosing schedule.

Time to Steady State

After starting (or changing) a dose, drug levels reach a new "steady state" after about 5 half-lives.

For Zepbound: with a 5-7 day half-life, steady state at a new dose is reached around 4-5 weeks. That's why dose increases are spaced ~4 weeks apart in the standard titration schedule.

How Long Zepbound Stays in Your System

A common question: "if I stop Zepbound, how long does it stay in my body?"

The standard rule of thumb is that a drug is essentially cleared after 5 half-lives. For Zepbound: that's approximately 25 days. Effects on appetite, glucose, or other targets persist for a similar period before fully resolving.

For incretin agents specifically, the appetite-related effects fade over weeks after stopping.

Practical Implications

A long half-life:

• Allows less frequent dosing (better adherence)
• Smooths out peaks and troughs (often better tolerability)
• Means dose changes take longer to fully express
• Creates a longer "runway" if a dose is missed

A short half-life:

• Requires more frequent dosing
• Produces sharper concentration peaks (and matching side effects)
• Allows faster dose adjustments
• Provides faster clearance if stopped

Zepbound, with its long half-life, falls on the long end of this spectrum.

Half-Life and Missed Doses

If a dose is missed:

• Take the missed dose as soon as you remember if you're well within the dosing interval
• Skip it if you're closer to the next dose
• Never double up

The longer the half-life, the more forgiving the missed-dose window. For Zepbound, the missed-dose window is relatively forgiving.

Half-Life Across the Drug Class

Within the broader class of dual gip / glp-1 receptor agonist, half-lives vary significantly. Daily agents (liraglutide) have shorter half-lives; weekly agents (semaglutide, dulaglutide, tirzepatide) have half-lives in the multi-day range. See our comparison pages for direct comparisons.

Bottom Line

Half-life is one of the cleaner numbers in pharmacology. For Zepbound, the approximately 5 days figure is the one you reference whenever timing comes up.

Frequently Asked Questions

Related Reading

• The Honest Guide to Zepbound: What Patients and Doctors Actually Say
• What Nobody Tells You About Zepbound Side Effects
• Zepbound Outcomes Decoded: Who Responds Best and Why
• Zepbound Cost Explained: Monthly, Yearly, and How to Save
• What Is Ozempic? Everything You Should Know Before Starting
• Is Ozempic Safe? An Honest Look at the Side-Effect Profile

Sources

• Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE). NEJM 2015;373:11.
• Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). NEJM 2023;389:2221.
• Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989.

This page is informational only and is not medical advice.